In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
Sign Up to like & getrecommendations! Published in 2018 at "Viruses"
DOI: 10.3390/v11010006
Abstract: Three neuraminidase inhibitors (NAIs: Oseltamivir, zanamivir and peramivir) are currently approved in many countries for the treatment of influenza A and B infections. The emergence of influenza B viruses (IBVs) containing mutations of cross-resistance to… read more here.
Keywords: properties virulence; influenza viruses; vitro properties; cross resistance ... See more keywords